Advertisement
Screener

SOLIGENIX, INC. (SNGX) Long-Term Debt, Maturity, Year Two

2.8 / 5 stars · 68/120 Roast Me

SOLIGENIX, INC. Long-Term Debt, Maturity, Year Two

SOLIGENIX, INC. (SNGX) had Long-Term Debt, Maturity, Year Two of $766.01 thousand as of 2023-12-31, per its 10-K filed 2024-03-15.

Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2024-03-15

  • 2023-12-31: Long-Term Debt, Maturity, Year Two $766.01K.
  • 2023-09-30: Long-Term Debt, Maturity, Year Two $766.01K.
  • 2023-06-30: Long-Term Debt, Maturity, Year Two $766.01K.
  • 2023-03-31: Long-Term Debt, Maturity, Year Two $766.01K.
Period endLong-Term Debt, Maturity, Year Two
2023-12-31$766.01K
10-K · filed 2024-03-15
2023-09-30$766.01K
10-Q · filed 2023-11-13
2023-06-30$766.01K
10-Q · filed 2023-08-21
2023-03-31$766.01K
10-Q · filed 2023-05-15
2022-12-31$4.30M
10-K · filed 2023-03-31
2022-09-30$4.38M
10-Q · filed 2022-11-10
2022-06-30$4.38M
10-Q · filed 2022-08-12
2022-03-31$4.38M
10-Q · filed 2022-05-13
2021-12-31$847.00K
10-K · filed 2022-03-29
2021-09-30$4.77M
10-Q · filed 2021-11-12
2021-06-30$897.00K
10-Q · filed 2021-08-13
2021-03-31$897.00K
10-Q · filed 2021-05-18
2020-12-31$897.00K
10-K · filed 2021-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Imunon, Inc. (IMNN)United States$0.008B-0.56
EXICURE, INC. (XCUR)United States$0.008B-1.54
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97